• PRILOCAINE CHEMBL1194 FDA Approved

    Alternate Names:

    Citanest
    BSPBIO_002604
    O-PROPIONOTOLUIDIDE, 2-PROPYLAMINO-
    PRILOCAINE BASE
    N-(2-METHYLPHENYL)-N2-PROPYLALANINAMIDE
    721-50-6
    NSC 40027
    O-METHYL-ALPHA-PROPYLAMINOPROPIONANILIDE
    PRESTWICK0_000199
    IDI1_000846
    O-METHYL-2-PROPYLAMINOPROPIONANILIDE
    KBIOSS_002129
    O-PROPIONOTOLUIDIDE, 2-(PROPYLAMINO)-
    PRILOCAINA
    BRD-A53952395-003-05-3
    KBIO2_002129
    2-METHYL-.ALPHA.-PROPYLAMINOPROPIONANILIDE
    AC-2100
    SPBIO_002078
    PRILOCAINUM [INN-LATIN]
    SPBIO_001398
    PROPITOCAINE
    DAP000511
    D00553
    AC1L1J7W
    KBIOGR_001883
    PRESTWICK3_000199
    PRILOCAINA [INN-SPANISH]
    SPECTRUM5_001175
    ALPHA-N-PROPYLAMINO-2-METHYLPROPIONANILIDE
    PRILOCAINUM
    PRILOCAINE [USAN]
    NCGC00015860-03
    S1619_SELLECK
    C07531
    PROPANAMIDE, N-(2-METHYLPHENYL)-2-(PROPYLAMINO)-
    NSC40027
    HSDB 3386
    KBIO2_007265
    ASTRA 1512
    PRESTWICK1_000199
    L 67
    BPBIO1_000173
    2-(PROPYLAMINO)-O-PROPIONOTOLUIDIDE
    AMBAP1786-81-8
    2-METHYL-ALPHA-PROPYLAMINOPROPIONANILIDE
    NINDS_000846
    EINECS 211-957-0
    CID4906
    BSPBIO_000157
    O-PROPIONOTULUIDIDE, 2-PROPYLAMINO-
    SPECTRUM4_001192
    LOPAC0_001005
    CHEBI:8404
    SPECTRUM_001649
    DB00750
    PRILOCAINE (USP/INN)
    9734
    N-(2-METHYLPHENYL)-N(2)-PROPYLALANINAMIDE
    AB00053665
    SPECTRUM3_001052
    DIVK1C_000846
    BRN 2108498
    4906
    ASTRA 1515
    PRESTWICK2_000199
    C13H20N2O
    KBIO2_004697
    UNII-046O35D44R
    SPECTRUM2_001549
    KBIO3_001824
    I01-1860
    NCGC00162312-01
    PROPANAMIDE, N-(2-METHYLPHENYL)-2-(PROPYLAMINO)- (9CI)
    KBIO1_000846
    MOLPORT-005-935-583
    PROPITOCAINE (JAN)
    LS-2304
    Q-100809
    N-(2-METHYLPHENYL)-2-(PROPYLAMINO)PROPANIMIDIC ACID
    3B2-1873
    A837435
    AB00053665-12
    .ALPHA.-N-PROPYL-AMINO-2-METHYLPROPIONANILIDE
    FT-0660568
    FT-0603506
    4CH-023339
    N-(2-METHYLPHENYL)-N~2~-PROPYLALANINAMIDE
    AB2000166
    OR332876
    OR220089
    O-METHYL-.ALPHA.-PROPYLAMINOPROPIONANILIDE
    DR000423
    BC209871
    AN-14288
    AK161940
    NCGC00015860-02
    PRILOCAINE-SUPPLIED BY SELLECK CHEMICALS
    N-(O-TOLYL)-2-(PROPYLAMINO)PROPANAMIDE
    NE41881
    MCULE-7176365958
    CS-1929
    CCG-205085
    AKOS015889404
    STL257086
    NSC-40027
    ABP000640
    HY-B0137
    ACT04759
    14289-31-7
    PRILOCAINE [USAN:USP:INN:BAN]
    HMS3604H09
    MVFGUOIZUNYYSO-UHFFFAOYSA-N
    CTK2H7603
    GTPL7276
    EBD798
    ARONIS27056
    SCHEMBL25467
    D-(-)-PRILOCAINE
    TAKIPRIL
    PRILOCAIN
    PRILOTEKALREG
    PRILOTEKAL
    2-(PROPYLAMINO)-N-(O-TOLYL)PROPANAMIDE
    178101605
    CARDIOTROPHIN-1
    CTF1

    Drug Info:

    Drug Class anesthetics, local
    Year of Approval approved before 1982
    Drug Indications for treatment of premature ejaculation
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications anesthetic
    Name of the Ligand Species (if a Peptide) Human
    (3 More Sources)

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? True

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Trial Name Oraqix
    Novel drug target Established target
    Trial Name PSD502, lidocaine + prilocaine

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Combination therapy Lidocaine, Prilocaine

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    CTF1 Gene Symbol (for Endogenous Peptides)
    CARDIOTROPHIN-1 GuideToPharmacology Ligand Name
    178101605 PubChem Drug SID

    Drug Info:
    Name of the Ligand Species (if a Peptide) Human

    Publications:

    • Version: 01-August-2011

    Alternate Names:

    Drug Info:
    Year of Approval approved before 1982
    Drug Class anesthetics, local

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications anesthetic
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    LS-2304 Drug Synonym
    721-50-6 Drug Synonym
    PROPITOCAINE (JAN) Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    4906 PubChem CID
    PROPITOCAINE Drug Synonym
    CITANEST Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 15-September-2017

    Alternate Names:

    Drug Info:

    Publications: